Emmanuel Haffen

Prof. Dr. Emmanuel Haffen

Department of Neuroscience, FondaMental Foundation, CIC-IT 808, University Hospital of Besançon, Besançon, France
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
ABAndre R. Brunoni
Andre R. Brunoni
AMAdriano H. Moffa
Adriano H. Moffa
Felipe FregniFelipe Fregni
Felipe Fregni
UPUlrich Palm
Ulrich Palm
FPFrank Padberg
Frank Padberg
CLColleen K Loo
Colleen K Loo
Background: Transcranial direct current stimulation (tDCS) is a non-pharmacological intervention for depression. It has mixed results, possibly caused by study heterogeneity.Aims: To assess tDCS efficacy and to explore individual response predictors.Method: Systematic review and individual patient data meta-analysis.Results: Data were gathered from six randomised sham-controlled trials, enrolling 289 patients. Active tDCS was significantly superior to sham for response (34% v. 19% respectively, odds ratio (OR) = 2.44, 95% CI 1.38–4.32, number needed to treat (NNT) = 7), remission (23.1% v. 12.7% respectively, OR = 2.38, 95% CI 1.22–4.64, NNT = 9) and depression improvement (B coefficient 0.35, 95% CI 0.12–0.57). Mixed-effects models showed that, after adjustment for other predictors and confounders, treatment-resistant depression and higher tDCS ‘doses' were, respectively, negatively and positively associated with tDCS efficacy.Conclusions: The effect size of tDCS treatment was comparable with those reported for repetitive transcranial magnetic stimulation and antidepressant drug treatment in primary care. The most important parameters for optimisation in future trials are depression refractoriness and tDCS dose.

30 October 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DBDjamila Bennabi
Djamila Bennabi
PVPierre Vandel
Pierre Vandel
CPCharalambos Papaxanthis
Charalambos Papaxanthis
TPThierry Pozzo
Thierry Pozzo
EHEmmanuel Haffen
Emmanuel Haffen
Psychomotor retardation is a central feature of depression which includes motor and cognitive impairments. Effective management may be useful to improve the classification of depressive subtypes and treatment selection, as well as prediction of outcome in patients with depression. The aim of this paper was to review the current status of knowledge regarding psychomotor retardation in depression, in order to clarify its role in the diagnostic management of mood disorders. Retardation modifies all the actions of the individual, including motility, mental activity, and speech. Objective assessments can highlight the diagnostic importance of psychomotor retardation, especially in melancholic and bipolar depression. Psychomotor retardation is also related to depression severity and therapeutic change and could be considered a good criterion for the prediction of therapeutic effect. The neurobiological process underlying the inhibition of activity includes functional deficits in the prefrontal cortex and abnormalities in dopamine neurotransmission. Future investigations of psychomotor retardation should help improve the understanding of the pathophysiological mechanisms underlying mood disorders and contribute to improving their therapeutic management.

1 July 2013 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
OAOlivier Andlauer
Olivier Andlauer
HMHyatt Moore
Hyatt Moore
LJLaura Jouhier
Laura Jouhier
Christopher Lawrence DrakeChristopher Lawrence Drake
Christopher Lawrence Drake
PPPaul E. Peppard
Paul E. Peppard
EMEmmanuel Mignot
Emmanuel Mignot
The association of excessive daytime sleepiness with cataplexy (episodes of muscle weakness triggered by emotions) has traditionally been used to define narcolepsy.1,2 In 1960, it was found that during nocturnal polysomnography (NPSG), 50% of cases have rapid transitions from wake to rapid eye movement (REM) sleep (sleep-onset REM periods [SOREMPs]).3,4 The Multiple Sleep Latency Test (MSLT), a test that allows 4 to 5 daytime nap opportunities for sleep onset and SOREMPs, was subsequently developed to increase sensitivity. A mean sleep latency (MSL) of 8 minutes or less and 2 or more SOREMPs is considered diagnostic for narcolepsy.2 Positive MSLT results have been reported in 2% to 4% of the population.5,6

26 August 2011 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
Sophia AchabSophia Achab
Sophia Achab
MNMagali Nicolier
Magali Nicolier
FMFred Mauny
Fred Mauny
JMJulie Monnin
Julie Monnin
BTBenoit Trojak
Benoit Trojak
EHEmmanuel Haffen
Emmanuel Haffen
Background: Massively Multiplayer Online Role-Playing Games (MMORPGs) are a very popular and enjoyable leisure activity, and there is a lack of international validated instruments to assess excessive gaming. With the growing number of gamers worldwide, adverse effects (isolation, hospitalizations, excessive use, etc.) are observed in a minority of gamers, which is a concern for society and for the scientific community. In the present study, we focused on screening gamers at potential risk of MMORPG addiction.Methods: In this exploratory study, we focused on characteristics, online habits and problematic overuse in adult MMORPG gamers. In addition to socio-demographical data and gamer behavioral patterns, 3 different instruments for screening addiction were used in French MMORPG gamers recruited online over 10 consecutive months: the substance dependence criteria for the Diagnostic and Statistical Manual of Mental Disorder, fourth revised edition (DSM-IV-TR) that has been adapted for MMORPG (DAS), the qualitative Goldberg Internet Addiction Disorder scale (GIAD) and the quantitative Orman Internet Stress Scale (ISS). For all scales, a score above a specific threshold defined positivity.Results: The 448 participating adult gamers were mainly young adult university graduates living alone in urban areas. Participants showed high rates of both Internet addiction (44.2% for GIAD, 32.6% for ISS) and DAS positivity (27.5%). Compared to the DAS negative group, DAS positive gamers reported significantly higher rates of tolerance phenomenon (increased amount of time in online gaming to obtain the desired effect) and declared significantly more social, financial (OR: 4.85), marital (OR: 4.61), family (OR: 4.69) and/or professional difficulties (OR: 4.42) since they started online gaming. Furthermore, these gamers self-reported significantly higher rates (3 times more) of irritability, daytime sleepiness, sleep deprivation due to play, low mood and emotional changes since online gaming onset.Conclusions: The DAS appeared to be a good first-line instrument to screen MMORPG addiction in online gamers. This study found high MMORPG addiction rates, and self-reported adverse symptoms in important aspects of life, including mood and sleep. This confirms the need to set up relevant prevention programs against online game overuse.

1 April 2020 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
AMAdriano H. Moffa
Adriano H. Moffa
DMDonel Martin
Donel Martin
AAAngelo Alonzo
Angelo Alonzo
DBDjamila Bennabi
Djamila Bennabi
DBDaniel M. Blumberger
Daniel M. Blumberger
ABAndre R. Brunoni
Andre R. Brunoni

1 December 2011 in Neurophysiologie Clinique
Verified
Journal Article
Closed access
JLJ.-P. Lefaucheur
J.-P. Lefaucheur
NANathalie André-Obadia
Nathalie André-Obadia
EPEmmanuel Poulet
Emmanuel Poulet
HDH. Devanne
H. Devanne
EHEmmanuel Haffen
Emmanuel Haffen
LGL. Garcia-Larrea
L. Garcia-Larrea